Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease.

Joyce D. Schroeder | E. Regan | R. Casaburi | J. Hokanson | T. Beaty | G. Washko | V. Kim | L. Washington | C. Mcevoy | B. Make | E. Silverman | J. Crapo | J. Ross | A. Díaz | M. Budoff | B. van Ginneken | B. Stoel | E. V. van Rikxoort | E. Kazerooni | A. Anzueto | G. Criner | P. Judy | J. Tschirren | G. Kinney | M. Cho | C. Hersh | H. Coxson | J. Weissfeld | F. Jacobson | F. Sciurba | J. Charbonnier | A. Sharafkhaneh | C. Lange | P. Castaldi | N. Hansel | R. Barr | D. Vummidi | S. Humphries | A. Notary | J. P. Centeno | J. Morrow | M. Foreman | S. Lutz | E. Wan | J. Hetmanski | C. Galbán | J. Newell | Silanath Terpenning | J. Schroeder | J. Wells | M. Dransfield | G. D'Alonzo | K. Kechris | P. Sakornsakolpat | D. Prokopenko | D. Qiao | B. Hobbs | A. Begnaud | A. Boriek | N. Putcha | A. Comellas | W. Labaki | M. Moll | E. Flenaugh | N. MacIntyre | B. Thomashow | J. Pórszász | Brianna Bell | N. Marchetti | H. Nath | J. Bon | C. Dass | R. Steiner | J. Tashjian | G. Westney | B. D’souza | S. Murray | F. Cordova | D. Ciccolella | K. Pratte | J. Sieren | K. Young | M. McDonald | P. Nardelli | K. Hoth | K. Kunisaki | William Bailey | D. Chandra | L. Hayden | N. Laird | A. Kluiber | R. Jensen | D. Everett | J. Crooks | M. Strand | P. Pernicano | Mustafa A. Atik | K. Guntupalli | E. Guy | A. Parulekar | R. Brown | Karen Horton | A. Lambert | A. Adami | Hans Fischer | Charlie Lan | R. Rosiello | D. Pace | P. Desai | S. Kelsen | A. Satti | K. Shenoy | A. Swift | I. Swift | M. Vega‐Sanchez | A. Iyer | A. Yen | T. Allen | S. Adams | Diego Maselli‐Caceres | M. E. Ruiz | Harjinder Singh | Aabida Saferali | A. Baldomero | Wonji Kim | A. El Boueiz | Auyon J. Ghosh | E. Austin | J. Yun | H. Gebrekristos | S. Fortis | J. Curtis | N. Hanania | C. Wilson | R. Bowler | A. Oh | D. Lynch | S. Bhatt | J. Billings | R. San José Estépar | Harry Rossiter | A. Mamary | Juerg Tschirren | J. Hokanson | D. Demeo | M. Han | R. Wise | Xavier Soler | Abbie Begnaud | E. A. Hoffman | Thu Tran | Edwin J.R. van Beek | Gonzalo Vegas Sanchez Ferrero | Lucas Veitel | Farnoush BanaeiKashani | J. Austin | H. McAdams | Will Stringer | Christine Wendt | Mario Ponce | Michael Jacobs | D.J. Conrad | Brad Thompson | J. Porszasz | E. Hoffman | William C. Bailey | Merry-Lynn N. McDonald | Gonzalo Vegas Sanchez- Ferrero | Robert Jensen | D. Conrad | Edwin K. Silverman | M. Budoff | Ella A. Kazerooni | John D. Newell | A. Saferali

[1]  G. A. Whitmore,et al.  Disease burden in individuals with symptomatic undiagnosed asthma or COPD. , 2022, Respiratory medicine.

[2]  Elizabeth M Webber,et al.  Screening for Chronic Obstructive Pulmonary Disease: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. , 2022, JAMA.

[3]  P. Raina,et al.  Prevalence and burden of COPD misclassification in the Canadian Longitudinal Study on Aging (CLSA) , 2022, BMJ Open Respiratory Research.

[4]  J. Curtis,et al.  Ratio of Forced Expiratory Volume in 1 second /Slow Vital Capacity (FEV1/SVC)<0.7 is associated with clinical, functional, and radiologic features of obstructive lung disease in smokers with preserved lung function. , 2021, Chest.

[5]  Sandra L. Decker,et al.  Prevalence and Treatment of Chronic Obstructive Pulmonary Disease (COPD) in the United States. , 2019, JAMA.

[6]  D. Culliford,et al.  COPD overdiagnosis in primary care: a UK observational study of consistency of airflow obstruction , 2019, npj Primary Care Respiratory Medicine.

[7]  F. Sciurba,et al.  Diagnosis and Outpatient Management of Chronic Obstructive Pulmonary Disease: A Review , 2019, JAMA.

[8]  V. Kim,et al.  Combined FEV1 and FVC Bronchodilator Response, Exacerbations, and Mortality in COPD. , 2019, Annals of the American Thoracic Society.

[9]  Junyan Wu,et al.  Triple therapy in the management of chronic obstructive pulmonary disease: systematic review and meta-analysis , 2018, British Medical Journal.

[10]  J. Hokanson,et al.  Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction. , 2018, Chronic obstructive pulmonary diseases.

[11]  T. To,et al.  Health Services Burden of Undiagnosed and Overdiagnosed COPD , 2018, Chest.

[12]  E. Arias,et al.  Mortality in the United States, 2016. , 2017, NCHS data brief.

[13]  B. Celli,et al.  Impact and prevention of severe exacerbations of COPD: a review of the evidence , 2017, International journal of chronic obstructive pulmonary disease.

[14]  B. Nordestgaard,et al.  Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. , 2017, The Lancet. Respiratory medicine.

[15]  M. Phipps,et al.  Screening for Chronic Obstructive Pulmonary Disease: US Preventive Services Task Force Recommendation Statement. , 2016, JAMA.

[16]  Meilan K. Han,et al.  Undiagnosed Obstructive Lung Disease in the United States. Associated Factors and Long-term Mortality. , 2015, Annals of the American Thoracic Society.

[17]  S. Dias,et al.  Efficacy and safety of long-acting β-agonist/long-acting muscarinic antagonist combinations in COPD: a network meta-analysis , 2015, Thorax.

[18]  P. Burney,et al.  Determinants of underdiagnosis of COPD in national and international surveys. , 2015, Chest.

[19]  C. Vogelmeier,et al.  COPD: early diagnosis and treatment to slow disease progression , 2015, International journal of clinical practice.

[20]  D. Price,et al.  Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort. , 2014, The Lancet. Respiratory medicine.

[21]  S. Stanojevic,et al.  Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations , 2012, European Respiratory Journal.

[22]  J. Concato,et al.  Use of Lambda-Mu-Sigma-Derived Z Score for Evaluating Respiratory Impairment in Middle-Aged Persons , 2011, Respiratory Care.

[23]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[24]  J. Hankinson,et al.  Interpretative strategies for lung function tests , 2005, European Respiratory Journal.

[25]  B. Willemse.  Smoking cessation in chronic obstructive pulmonary disease , 2005 .